Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer

间变性淋巴瘤激酶 免疫组织化学 肺癌 医学 克里唑蒂尼 ROS1型 腺癌 内科学 肿瘤科 癌症研究 病理 癌症 恶性胸腔积液
作者
Ruiying Zhao,Lianying Guo,Bo Zhang,Jingming Zhao,Chan Xiang,Shengnan Chen,Jinchen Shao,Lei Zhu,Min Yang,Yuchen Han
标识
DOI:10.1002/cjp2.289
摘要

This study aimed to present a comprehensive assessment of anaplastic lymphoma kinase (ALK) rearrangements evaluated by DNA/RNA-based next-generation sequencing (NGS) and Ventana immunohistochemistry (IHC) in patients with non-small-cell lung cancer (NSCLC) and to evaluate the therapeutic outcomes of ALK tyrosine kinase inhibitor (TKI) treatment. We investigated ALK gene fusions in 14,894 patients with NSCLC using Ventana IHC and NGS, including 12,533 cases detected via DNA-based NGS and 2,361 cases using RNA-based NGS. The overall percentage agreement (OPA), positive percentage agreement (PPA), and negative percentage agreement (NPA) were calculated when comparing the results between NGS and IHC. The therapeutic responses to ALK-TKIs were also evaluated. In total, 3.50% (439/12,533) of specimens were NGS ALK-positive (NGS-p) in the DNA-based NGS cohort and 3.63% (455/12,533) were IHC ALK-positive (IHC-p). The OPA of NGS was 99.60%, whereas its PPA and NPA were 92.75 and 99.86%, respectively. In the adenocarcinoma (ADC) subcohort, the PPA was 95.69%. In the RNA-based NGS cohort, 2.20% (52/2,361) of specimens were NGS-p and 2.63% (62/2,361) were IHC-p. The OPA of NGS was 99.49%; its PPA and NPA were 82.26 and 99.96%, respectively. Thirteen patients with discordant results received ALK-TKI treatment. In the seven NGS-p/IHC-negative (IHC-n) patients, the overall response rate (ORR) was 85.4% (6/7) and the disease control rate (DCR) was 100%. In the six NGS-negative/IHC-p patients, the ORR was 66.7% (4/6) and the DCR was 100%. In summary, a high concordance of ALK gene fusion detected via NGS and IHC was observed in this study. DNA-based NGS had a higher OPA, PPA, and PPA in the ADC subcohort, whereas RNA-based NGS had a higher NPA. Overall, the results suggest that the combination of NGS and IHC can improve the accuracy of ALK fusion detection; hence, a result determination algorithm for clinical detection of ALK gene fusion was also proposed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
苹果追命完成签到,获得积分10
1秒前
yi发布了新的文献求助10
1秒前
不以完成签到,获得积分10
1秒前
大模型应助抗氧剂采纳,获得10
2秒前
燎原发布了新的文献求助10
3秒前
3秒前
舒心海白发布了新的文献求助10
3秒前
阿艺完成签到,获得积分10
3秒前
可取完成签到,获得积分10
3秒前
柚子完成签到,获得积分10
4秒前
温暖的孤兰完成签到 ,获得积分10
5秒前
chaser完成签到,获得积分10
5秒前
卡戎529完成签到 ,获得积分10
5秒前
Winfrednano完成签到,获得积分10
6秒前
aaaa完成签到 ,获得积分10
7秒前
麦麦完成签到,获得积分10
7秒前
mao完成签到,获得积分10
8秒前
自信的完成签到,获得积分10
8秒前
科研人完成签到,获得积分10
8秒前
顺利滑板完成签到,获得积分10
8秒前
小北完成签到,获得积分10
8秒前
陌路完成签到,获得积分10
9秒前
9秒前
野性的马里奥完成签到,获得积分10
9秒前
9秒前
hhhh完成签到,获得积分10
9秒前
wen雯完成签到,获得积分10
10秒前
嫁接诺贝尔完成签到,获得积分10
10秒前
心灵美亦寒完成签到,获得积分10
11秒前
沈尔云完成签到,获得积分10
12秒前
emm完成签到,获得积分10
12秒前
wukong完成签到,获得积分10
12秒前
海带完成签到 ,获得积分10
12秒前
xuan完成签到 ,获得积分10
12秒前
TheDay完成签到,获得积分10
13秒前
Tang发布了新的文献求助10
13秒前
星辰大海应助繁荣的从阳采纳,获得10
14秒前
kk完成签到,获得积分10
14秒前
Gjt完成签到,获得积分20
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
The Cambridge History of China 英文版16册 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7331872
求助须知:如何正确求助?哪些是违规求助? 8946273
关于积分的说明 18976809
捐赠科研通 6986121
什么是DOI,文献DOI怎么找? 3216880
关于科研通互助平台的介绍 2383436
邀请新用户注册赠送积分活动 2196584